Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (261-270 of 299) with videos related to

Pageof 30
Sort By:
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
Oncogene|February 19, 1998
Expression of p16 induces transcriptional downregulation of the RB geneX Fang, X Jin, H J Xu, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Blood|June 1, 1994
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow supportE J Shpall, S M Stemmer, L Hami, et al.
Cancer|August 27, 1999
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illnessW F Baile, A P Kudelka, E A Beale, et al.
International Journal of Cancer|July 15, 1999
Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185C M Boyer, L Pusztai, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alphaS Wu, K Rodabaugh, O Martinez-Maza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomasY Yu, F Xu, H Peng, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
Pageof 30

Showing results (261-270 of 299) with videos related to

Sort By:
Pageof 30
Human Pathology|November 1, 1996
Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinomaF A van den Brule, C Buicu, A Berchuck, et al.
Oncogene|February 19, 1998
Expression of p16 induces transcriptional downregulation of the RB geneX Fang, X Jin, H J Xu, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Blood|June 1, 1994
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow supportE J Shpall, S M Stemmer, L Hami, et al.
Cancer|August 27, 1999
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illnessW F Baile, A P Kudelka, E A Beale, et al.
International Journal of Cancer|July 15, 1999
Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185C M Boyer, L Pusztai, J R Wiener, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alphaS Wu, K Rodabaugh, O Martinez-Maza, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 1999
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomasY Yu, F Xu, H Peng, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial TrustF Balkwill, R C Bast, J Berek, et al.
Pageof 30